Inhaled Corticosteroid Escalation After a Single Moderate Exacerbation in COPD : Differential Benefit by Exacerbation Subtype

Study limitation reported by the research below: “The impact flag 'practice changing' is applied because findings directly challenge a uniform ICS escalation approach after any single moderate exacerbation, but replication in non-Asian populations is needed before broad adoption.”